• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

孕期混合免疫对严重急性呼吸综合征冠状病毒2(SARS-CoV-2)的中和及结合抗体反应

Neutralizing and binding antibody responses to SARS-CoV-2 with hybrid immunity in pregnancy.

作者信息

Li Lin, Matsui Yusuke, Prahl Mary K, Cassidy Arianna G, Golan Yarden, Jigmeddagva Unurzul, Ozarslan Nida, Lin Christine Y, Buarpung Sirirak, Gonzalez Veronica J, Chidboy Megan A, Basilio Emilia, Lynch Kara L, Song Dongli, Jegatheesan Priya, Rai Daljeet S, Govindaswami Balaji, Needens Jordan, Rincon Monica, Myatt Leslie, Taha Taha Y, Montano Mauricio, Ott Melanie, Greene Warner C, Gaw Stephanie L

机构信息

Division of Maternal-Fetal Medicine, Department of Obstetrics, Gynecology, and Reproductive Sciences, University of California San Francisco, San Francisco, CA, USA.

Department of Obstetrics, Gynecology, and Reproductive Sciences, Center for Reproductive Sciences, University of California San Francisco, San Francisco, CA, USA.

出版信息

NPJ Vaccines. 2024 Aug 27;9(1):156. doi: 10.1038/s41541-024-00948-3.

DOI:10.1038/s41541-024-00948-3
PMID:39191763
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11349990/
Abstract

Hybrid immunity against SARS-CoV-2 has not been well studied in pregnancy. We conducted a comprehensive analysis of neutralizing antibodies (nAb) and binding antibodies in pregnant individuals who received mRNA vaccination, natural infection, or both. A third vaccine dose augmented nAb levels compared to the two-dose regimen or natural infection alone; this effect was more pronounced in hybrid immunity. There was reduced anti-Omicron nAb, but the maternal-fetal transfer efficiency remained comparable to that of other variants. Vaccine-induced nAbs were transferred more efficiently than infection-induced nAbs. Anti-spike receptor binding domain (RBD) IgG was associated with nAb against wild-type (Wuhan-Hu-1) following breakthrough infection. Both vaccination and infection-induced anti-RBD IgA, which was more durable than anti-nucleocapsid IgA. IgA response was attenuated in pregnancy compared to non-pregnant controls. These data provide additional evidence of augmentation of humoral immune responses in hybrid immunity in pregnancy.

摘要

针对严重急性呼吸综合征冠状病毒2(SARS-CoV-2)的混合免疫在孕期尚未得到充分研究。我们对接受信使核糖核酸(mRNA)疫苗接种、自然感染或两者皆有的孕妇的中和抗体(nAb)和结合抗体进行了全面分析。与两剂接种方案或仅自然感染相比,第三剂疫苗增强了nAb水平;这种效应在混合免疫中更为明显。抗奥密克戎nAb有所降低,但母胎转移效率与其他变体相当。疫苗诱导的nAb比感染诱导的nAb转移效率更高。突破性感染后,抗刺突受体结合域(RBD)IgG与针对野生型(武汉-1)的nAb相关。接种疫苗和感染均诱导产生抗RBD IgA,其比抗核衣壳IgA更持久。与非孕对照组相比,孕期IgA反应减弱。这些数据为孕期混合免疫中体液免疫反应增强提供了更多证据。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6c28/11349990/83c0a73c04a3/41541_2024_948_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6c28/11349990/a55f910341eb/41541_2024_948_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6c28/11349990/89bc484396c3/41541_2024_948_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6c28/11349990/db82e27652a2/41541_2024_948_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6c28/11349990/cf8a78cc9a98/41541_2024_948_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6c28/11349990/5eeef566b49c/41541_2024_948_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6c28/11349990/83c0a73c04a3/41541_2024_948_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6c28/11349990/a55f910341eb/41541_2024_948_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6c28/11349990/89bc484396c3/41541_2024_948_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6c28/11349990/db82e27652a2/41541_2024_948_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6c28/11349990/cf8a78cc9a98/41541_2024_948_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6c28/11349990/5eeef566b49c/41541_2024_948_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6c28/11349990/83c0a73c04a3/41541_2024_948_Fig6_HTML.jpg

相似文献

1
Neutralizing and binding antibody responses to SARS-CoV-2 with hybrid immunity in pregnancy.孕期混合免疫对严重急性呼吸综合征冠状病毒2(SARS-CoV-2)的中和及结合抗体反应
NPJ Vaccines. 2024 Aug 27;9(1):156. doi: 10.1038/s41541-024-00948-3.
2
SARS-CoV-2 Infection-and mRNA Vaccine-induced Humoral Immunity among Schoolchildren in Hawassa, Ethiopia.埃塞俄比亚霍瓦萨地区学龄儿童中的 SARS-CoV-2 感染和 mRNA 疫苗诱导的体液免疫。
Front Immunol. 2023 Jun 15;14:1163688. doi: 10.3389/fimmu.2023.1163688. eCollection 2023.
3
Sequence Matters: Primary COVID-19 Vaccination after Infection Elicits Similar Anti-spike Antibody Levels, but Stronger Antibody Dependent Cell-mediated Cytotoxicity than Breakthrough Infection.序列很重要:感染后进行初级 COVID-19 疫苗接种会引起相似的刺突抗体水平,但比突破性感染产生更强的抗体依赖的细胞介导的细胞毒性。
J Immunol. 2024 Oct 15;213(8):1105-1114. doi: 10.4049/jimmunol.2400250.
4
Trends of humoral immune responses to heterologous antigenic exposure due to vaccination & omicron SARS-CoV-2 infection: Implications for boosting.由于疫苗接种和奥密克戎 SARS-CoV-2 感染导致的针对异源抗原暴露的体液免疫反应趋势:对增强作用的影响。
Indian J Med Res. 2023 Jun;157(6):509-518. doi: 10.4103/ijmr.ijmr_2521_22.
5
Diversified humoral immunity and impacts of booster vaccines: SARS-CoV-2 antibody profile and Omicron BA.2 neutralization before and after first or second boosters.多元化的体液免疫和加强疫苗的影响:初次或第二次加强针前后 SARS-CoV-2 抗体特征和奥密克戎 BA.2 的中和作用。
Microbiol Spectr. 2024 Oct 3;12(10):e0060524. doi: 10.1128/spectrum.00605-24. Epub 2024 Aug 20.
6
Efficacy of the neutralizing antibodies after the booster dose on SARS-CoV-2 Omicron variant and a two-year longitudinal antibody study on Wild Type convalescents.加强针后针对 SARS-CoV-2 奥密克戎变异株的中和抗体效力和对野生型恢复期患者的两年纵向抗体研究。
Int Immunopharmacol. 2023 Jun;119:110151. doi: 10.1016/j.intimp.2023.110151. Epub 2023 Apr 5.
7
Distinct features of SARS-CoV-2 humoral immunity against Omicron breakthrough infection.奥密克戎突破性感染中针对 SARS-CoV-2 体液免疫的独特特征。
Vaccine. 2023 Nov 13;41(47):7019-7025. doi: 10.1016/j.vaccine.2023.10.035. Epub 2023 Oct 17.
8
Characterization of the SARS-CoV-2 antibody landscape in Norway in the late summer of 2022: high seroprevalence in all age groups with patterns of primary Omicron infection in children and hybrid immunity in adults.2022 年夏末挪威的 SARS-CoV-2 抗体特征:所有年龄段的血清阳性率都很高,儿童中主要为奥密克戎感染模式,成人中为混合免疫。
BMC Infect Dis. 2024 Aug 20;24(1):841. doi: 10.1186/s12879-024-09670-w.
9
Hybrid Immunity Shifts the Fc-Effector Quality of SARS-CoV-2 mRNA Vaccine-Induced Immunity.杂合免疫改变了 SARS-CoV-2 mRNA 疫苗诱导免疫的 Fc 效应子质量。
mBio. 2022 Oct 26;13(5):e0164722. doi: 10.1128/mbio.01647-22. Epub 2022 Aug 24.
10
Durability of ChAdOx1 nCoV-19 (AZD1222) vaccine and hybrid humoral immunity against variants including omicron BA.1 and BA.4 6 months after vaccination (COV005): a post-hoc analysis of a randomised, phase 1b-2a trial.腺病毒载体新冠疫苗 ChAdOx1 nCoV-19(AZD1222)的持久性和对包括奥密克戎 BA.1 和 BA.4 在内的变异株的混合体液免疫:接种后 6 个月的一项随机、1b-2a 期临床试验的事后分析。
Lancet Infect Dis. 2023 Mar;23(3):295-306. doi: 10.1016/S1473-3099(22)00596-5. Epub 2022 Oct 20.

引用本文的文献

1
Pregnancy and lactation induce distinct immune responses to COVID-19 booster vaccination and SARS-CoV-2 breakthrough infection.怀孕和哺乳会引发对新冠病毒加强疫苗接种和新冠病毒突破性感染的不同免疫反应。
JCI Insight. 2025 Jul 22;10(14). doi: 10.1172/jci.insight.191930.

本文引用的文献

1
Non-neutralizing SARS-CoV-2 N-terminal domain antibodies protect mice against severe disease using Fc-mediated effector functions.非中和性 SARS-CoV-2 N 端结构域抗体通过 Fc 介导的效应功能保护小鼠免受严重疾病。
PLoS Pathog. 2024 Jun 20;20(6):e1011569. doi: 10.1371/journal.ppat.1011569. eCollection 2024 Jun.
2
Seroprevalence and placental transfer of SARS-CoV-2 antibodies in unvaccinated pregnant women.未接种疫苗孕妇的 SARS-CoV-2 抗体血清阳性率与胎盘转移。
BMC Infect Dis. 2024 May 21;24(1):509. doi: 10.1186/s12879-024-09399-6.
3
Maternal hybrid immunity and risk of infant COVID-19 hospitalizations: national case-control study in Israel.
母体混合免疫与婴儿 COVID-19 住院风险:以色列全国病例对照研究。
Nat Commun. 2024 Apr 2;15(1):2846. doi: 10.1038/s41467-024-46694-x.
4
Seroepidemiology of SARS-CoV-2 in a cohort of pregnant women and their infants in Uganda and Malawi.SARS-CoV-2 在乌干达和马拉维的一组孕妇及其婴儿中的血清流行病学研究。
PLoS One. 2024 Mar 1;19(3):e0290913. doi: 10.1371/journal.pone.0290913. eCollection 2024.
5
Analysis of the transplacental transmission of SARS CoV-2 virus and antibody transfer according to the gestational age at maternal infection.根据母体感染时的孕周分析 SARS CoV-2 病毒的胎盘传播和抗体转移。
Sci Rep. 2024 Feb 11;14(1):3458. doi: 10.1038/s41598-024-53580-5.
6
IgG antibody levels against the SARS-CoV-2 spike protein in mother-child dyads after COVID-19 vaccination.母亲-儿童对 COVID-19 疫苗接种后 SARS-CoV-2 刺突蛋白的 IgG 抗体水平。
Infection. 2024 Jun;52(3):813-824. doi: 10.1007/s15010-023-02111-x. Epub 2023 Oct 28.
7
Diverging Maternal and Cord Antibody Functions From SARS-CoV-2 Infection and Vaccination in Pregnancy.母胎和脐带抗体功能在妊娠期间对 SARS-CoV-2 感染和疫苗接种的影响存在差异。
J Infect Dis. 2024 Feb 14;229(2):462-472. doi: 10.1093/infdis/jiad421.
8
Comparison of Anti-SARS-CoV-2-Specific Antibody Signatures in Maternal and Infant Blood after COVID-19 Infection versus COVID-19 Vaccination during Pregnancy.母亲感染 COVID-19 与妊娠期间接种 COVID-19 疫苗后母婴血液中抗 SARS-CoV-2 特异性抗体特征的比较。
Am J Perinatol. 2024 May;41(S 01):e2970-e2977. doi: 10.1055/a-2183-9109. Epub 2023 Sep 29.
9
Characteristics of Vaccine- and Infection-Induced Systemic IgA Anti-SARS-CoV-2 Spike Responses.疫苗诱导和感染诱导的全身性IgA抗SARS-CoV-2刺突反应的特征
Vaccines (Basel). 2023 Sep 7;11(9):1462. doi: 10.3390/vaccines11091462.
10
Reduced maternal immunity and vertical transfer of immunity against SARS-CoV-2 variants of concern with COVID-19 exposure or initial vaccination in pregnancy.母亲免疫力降低,以及 COVID-19 暴露或初次接种疫苗期间对 SARS-CoV-2 关切变异株的垂直传递免疫。
Front Immunol. 2023 Sep 11;14:1216410. doi: 10.3389/fimmu.2023.1216410. eCollection 2023.